
Please try another search
Mycenax Biotech Inc. provides biopharmaceutical services and solutions for drug development and production in Taiwan. The company’s services include program evaluation/confirmation, cell line development and construction, process development technology platforms, drug characterization analysis, establishment of testing methods, and PIC/S GMP drug production. It offers plasmid DNA, antibody-drug conjugates, cell and gene therapy, and exosomes products and services. The company was founded in 2001 and is headquartered in Zhubei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Kuo-Pin Kao | - | 2013 | Independent Director |
Jung-Chin Lin | 70 | 2024 | Director |
Chun-Hong Chen | - | 2014 | Director |
Pei-Jiun Chen | - | 2022 | President CEO & Chairman |
Yu-Sheng Tsai | - | 2019 | Independent Director |
Yi-hsin Lee | - | 2024 | Director |
Maggie Lu | - | 2025 | Independent Director |
Kuo-Lung Yen | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review